BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24252689)

  • 21. Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study.
    Klein R; Roggendorf W
    Acta Neuropathol; 2001 Mar; 101(3):245-8. PubMed ID: 11307624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.
    Nakamizo A; Inamura T; Ikezaki K; Yoshimoto K; Inoha S; Mizoguchi M; Amano T; Fukui M
    J Neurooncol; 2002 Apr; 57(2):105-14. PubMed ID: 12125970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas.
    Platten M; Giordano MJ; Dirven CM; Gutmann DH; Louis DN
    Am J Pathol; 1996 Aug; 149(2):621-7. PubMed ID: 8702000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Celecoxib desensitization: continued temozolomide/celecoxib chemotherapy after a celecoxib-induced hypersensitivity reaction.
    Burbach GJ; Vajkoczy P; Zuberbier T
    Anticancer Drugs; 2012 Nov; 23(10):1118-20. PubMed ID: 23026982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study.
    Chen L; He Y; Huang H; Liao H; Wei W
    Med Oncol; 2008; 25(2):161-71. PubMed ID: 18172786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
    Stein EA; Ballantyne CM; Windler E; Sirnes PA; Sussekov A; Yigit Z; Seper C; Gimpelewicz CR
    Am J Cardiol; 2008 Feb; 101(4):490-6. PubMed ID: 18312764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib.
    Kardosh A; Golden EB; Pyrko P; Uddin J; Hofman FM; Chen TC; Louie SG; Petasis NA; Schönthal AH
    Cancer Res; 2008 Feb; 68(3):843-51. PubMed ID: 18245486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
    Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
    Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilocytic astrocytoma: a disease with evolving molecular heterogeneity.
    Sadighi Z; Slopis J
    J Child Neurol; 2013 May; 28(5):625-32. PubMed ID: 23439714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple cystic brain lesions in a patient with pilocytic astrocytoma.
    Senaratna S; Hanieh A; Manson J; Toogood I
    J Clin Neurosci; 2001 Jul; 8(4):363-6. PubMed ID: 11437582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
    Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
    Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluvastatin inhibits hepatitis C replication in humans.
    Bader T; Fazili J; Madhoun M; Aston C; Hughes D; Rizvi S; Seres K; Hasan M
    Am J Gastroenterol; 2008 Jun; 103(6):1383-9. PubMed ID: 18410471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution.
    Colin C; Padovani L; Chappé C; Mercurio S; Scavarda D; Loundou A; Frassineti F; André N; Bouvier C; Korshunov A; Lena G; Figarella-Branger D
    Neuropathol Appl Neurobiol; 2013 Oct; 39(6):693-705. PubMed ID: 23278243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Celecoxib combined with atorvastatin prevents progression of atherosclerosis.
    Raval M; Frank PG; Laury-Kleintop L; Yan G; Lanza-Jacoby S
    J Surg Res; 2010 Oct; 163(2):e113-22. PubMed ID: 20538289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomas.
    Jeyapalan JN; Doctor GT; Jones TA; Alberman SN; Tep A; Haria CM; Schwalbe EC; Morley IC; Hill AA; LeCain M; Ottaviani D; Clifford SC; Qaddoumi I; Tatevossian RG; Ellison DW; Sheer D
    Acta Neuropathol Commun; 2016 May; 4(1):54. PubMed ID: 27229157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.
    Cheng Y; Pang JC; Ng HK; Ding M; Zhang SF; Zheng J; Liu DG; Poon WS
    Histopathology; 2000 Nov; 37(5):437-44. PubMed ID: 11119125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged low-dose administration of the cyclooxygenase-2 inhibitor celecoxib enhances the antitumor activity of irinotecan against neuroblastoma xenografts.
    Kaneko M; Kaneko S; Suzuki K
    Cancer Sci; 2009 Nov; 100(11):2193-201. PubMed ID: 19673886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial).
    Ostadal P; Alan D; Vejvoda J; Kukacka J; Macek M; Hajek P; Mates M; Kvapil M; Kettner J; Wiendl M; Aschermann O; Slaby J; Holm F; Telekes P; Horak D; Blasko P; Zemanek D; Veselka J; Cepova J
    Trials; 2010 May; 11():61. PubMed ID: 20500832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diencephalic pilocytic astrocytoma with clinical onset in infancy. Biological behavior and pathomorphological findings in 11 children].
    Jänisch W; Schreiber D; Martin H; Gerlach H
    Zentralbl Allg Pathol; 1985; 130(1):31-43. PubMed ID: 3984542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.
    Zhao Y; Hao Y; Ji H; Fang Y; Guo Y; Sha W; Zhou Y; Pang X; Southerland WM; Califano JA; Gu X
    Cancer Prev Res (Phila); 2010 Jun; 3(6):787-96. PubMed ID: 20501859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.